Ugo De Giorgi

Ugo De Giorgi

UNVERIFIED PROFILE

Are you Ugo De Giorgi?   Register this Author

Register author
Ugo De Giorgi

Ugo De Giorgi

Publications by authors named "Ugo De Giorgi"

Are you Ugo De Giorgi?   Register this Author

100Publications

2499Reads

30Profile Views

AR Copy Number and AR Signaling-directed Therapies in Castrationresistant Prostate Cancer.

Curr Cancer Drug Targets 2018 ;18(9):869-876

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568009617666171122145852DOI Listing
September 2019

Early use of abiraterone and radium-223 in metastatic prostate cancer.

Lancet Oncol 2019 May;20(5):e228

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30226-8DOI Listing
May 2019

Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches.

Int J Mol Sci 2019 May 25;20(10). Epub 2019 May 25.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola 47014, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms20102569DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566239PMC
May 2019

Reclassification of good-risk seminoma: prognostic factors, novel biomarkers and implications for clinical management.

Future Oncol 2019 Apr 18;15(12):1347-1352. Epub 2019 Mar 18.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0850DOI Listing
April 2019

Severe Complications in Testicular Germ Cell Tumors: The Choriocarcinoma Syndrome.

Front Endocrinol (Lausanne) 2019 12;10:218. Epub 2019 Apr 12.

2nd Department of Oncology, Faculty of Medicine, National Cancer Institute, Comenius University, Bratislava, Slovakia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fendo.2019.00218DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6474390PMC
April 2019

Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer.

Radiol Med 2018 Dec 16;123(12):952-965. Epub 2018 Aug 16.

Nuclear Medicine Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11547-018-0929-9DOI Listing
December 2018

Vitiligo-like lesions in a patient treated with nivolumab for renal cell carcinoma.

Medicine (Baltimore) 2018 Dec;97(52):e13810

Skin Cancer Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00005792-201812280-0004
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000013810DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314787PMC
December 2018

Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients.

Eur J Nucl Med Mol Imaging 2018 11 19;45(12):2035-2044. Epub 2018 Jun 19.

Nuclear Medicine Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-018-4067-3DOI Listing
November 2018

Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry.

J Clin Oncol 2018 Oct 4:JCO1800210. Epub 2018 Oct 4.

Richard Cathomas, Kantonsspital Graubünden, Chur; Dirk Klingbiel, Swiss Group for Clinical Cancer Research Coordinating Center; Silke Gillessen, University of Bern; Jörg Beyer, Inselspital, Bern University Hospital, University of Bern, Bern; Christian Fankhauser, University of Zürich, Zürich; Silke Gillessen, Kantonsspital St Gallen, St Gallen, Switzerland; Brandon Bernard, Dana-Farber Cancer Institute, Boston, MA; Anja Lorch, University of Düsseldorf, Düsseldorf; Christoph Oing, University Medical Center Hamburg-Eppendorf, Hamburg; Marcus Hentrich, Rotkreuzklinikum München, München, Germany; Xavier Garcia del Muro, Institute Catalan of Oncology, Bellvitge Biomedical Research Institute, University of Barcelona, Barcelona, Spain; Franco Morelli, Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituto di Ricovero e Cura a Carattere Scientifico, Meldola, Italy; Mikhail Fedyanin, N.N. Blokhin National Medical Research Center of Oncology, Moscow, Russia; and Hege Sagstuen Haugnes, University Hospital of North Norway and Universitetet i Tromsø-The Arctic University, Tromsø, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.00210DOI Listing
October 2018

Reply to the letter to the editor 'Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer' by Yang et al.

Ann Oncol 2018 08;29(8):1879-1880

Division of Internal Medicine and Clinical Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari "Aldo Moro", Bari, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/annonc/mdy176DOI Listing
August 2018

[Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet?

Lancet Oncol 2018 06 8;19(6):725-726. Epub 2018 May 8.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituto di Ricovero e Cura a Carattere Scientifico (IRST) IRCCS, 47014 Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30268-7DOI Listing
June 2018

Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?

Expert Opin Drug Metab Toxicol 2018 Apr 23;14(4):461-467. Epub 2018 Mar 23.

b Oncology Unit , IRCCS IRST , Meldola , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2018.1455826DOI Listing
April 2018

Systemic immune-inflammation index in germ-cell tumours.

Br J Cancer 2018 03 27;118(6):831-838. Epub 2018 Feb 27.

Second Department of Oncology, Faculty of Medicine, Comenius University, Klenova 1, Bratislava 833 10, Slovakia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2017.460DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877428PMC
March 2018

Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors.

Adv Urol 2018 13;2018:3718165. Epub 2018 Mar 13.

2nd Department of Oncology, Faculty of Medicine, Comenius University, National Cancer Institute, Bratislava, Slovakia.

View Article

Download full-text PDF

Source
https://www.hindawi.com/journals/au/2018/3718165/
Publisher Site
http://dx.doi.org/10.1155/2018/3718165DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872660PMC
March 2018

Re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680-7.

Eur Urol 2018 01 6;73(1):e9-e10. Epub 2017 Aug 6.

Biostatistics and Clinical Trials Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.07.032DOI Listing
January 2018

Molecular Mechanisms of Resistance in Testicular Germ Cell Tumors - clinical Implications.

Curr Cancer Drug Targets 2018 ;18(10):967-978

Translational Research Unit, Faculty of Medicine, Comenius University; National Cancer Institute, Bratislava, Slovakia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568009618666180102103959DOI Listing
January 2018

Reduction of Ga-PSMA renal uptake with mannitol infusion: preliminary results.

Eur J Nucl Med Mol Imaging 2017 Dec 11;44(13):2189-2194. Epub 2017 Aug 11.

Nuclear Medicine Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-017-3791-4DOI Listing
December 2017

Immunotherapy for Prostate Cancer: Where We Are Headed.

Int J Mol Sci 2017 Dec 5;18(12). Epub 2017 Dec 5.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014 Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/ijms18122627DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751230PMC
December 2017

Urinary RNA-based biomarkers for prostate cancer detection.

Clin Chim Acta 2017 Oct 12;473:96-105. Epub 2017 Aug 12.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, Meldola 47014, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2017.08.009DOI Listing
October 2017

Consider Quality of Life to Improve Quality of Cancer Guidelines.

JAMA Intern Med 2017 10;177(10):1537

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamainternmed.2017.3694DOI Listing
October 2017

A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer.

Oncologist 2017 07 25;22(7):784-e74. Epub 2017 May 25.

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507652PMC
July 2017

GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications.

Dis Markers 2016 10;2016:4358292. Epub 2016 Aug 10.

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014 Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/4358292DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995330PMC
February 2017

High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors: A Retrospective Study of the European Society for Blood and Marrow Transplantation.

Int J Gynecol Cancer 2017 02;27(2):248-251

*Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy; †Centre Leon Berard, Lyon; and ‡EBMT Paris Office, Paris, France; §Universitatsklinikum Frankfurt, Frankfurt, Germany; ∥Hopital Tenon, Paris, France; ¶University Hospital Gasthuisberg, Leuven, Belgium; and #Hematology Unit, Ravenna Hospital, Ravenna; and **Ospedale di Busto Arsizio, Varese, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000882DOI Listing
February 2017

The potential use of urine cell free DNA as a marker for cancer.

Expert Rev Mol Diagn 2016 12 10;16(12):1283-1290. Epub 2016 Nov 10.

a Biosciences Laboratory , Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS , Meldola , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2016.1254551DOI Listing
December 2016

Androgen receptor signaling pathways as a target for breast cancer treatment.

Endocr Relat Cancer 2016 10 15;23(10):R485-98. Epub 2016 Aug 15.

Department of Medical OncologyIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Forlì-Cesena, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-16-0190DOI Listing
October 2016

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.

Front Pharmacol 2016 13;7:376. Epub 2016 Oct 13.

Medical Oncology Department, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituto di Ricovero e Cura a Carattere Scientifico Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2016.00376DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062111PMC
October 2016

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.

J Clin Oncol 2016 09 11;34(25):3005-13. Epub 2016 Jul 11.

Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori-Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d'Instruction des Armées Val-de-Grâce; Stéphane Oudard, European Hospital Georges Pompidou and Paris Descartes University, Paris; Antoine Thiery-Vuillemin, Jean Minjoz Hospital, Besançon; Nadine Houédé, Institut de Cancérologie du Gard-Centre Hospitalier Universitaire Caremeau, Nîmes; Karim Fizazi, Institute Gustave Roussy, University of Paris Sud, Villejuif, France; Michael Krainer, Medical University of Vienna, Vienna, Austria; Andries Bergman, Netherlands Cancer Institute, Amsterdam; Ronald De Wit, Erasmus University Medical Center and Cancer Institute, Rotterdam, the Netherlands; Wolfgang Hoelzer, Praxis für Urologie; Kurt Miller, Charité-Universitätsmedizin Berlin, Berlin; Martin Bögemann, University of Muenster Medical Center, Muenster; Susan Feyerabend, Studienpraxis Urologie, Nürtingen; Arnulf Stenzl, University Hospital, Tübingen, Germany; Fred Saad, Centre Hospitalier de I'Université de Montréal, Montreal, Quebec, Canada; Elaine Lam, University of Colorado Anschutz Medical Campus, Aurora, CO; Jonathan Polikoff, Kaiser Permanente Medical Group, San Diego; David Ramies, Colin Hessel, and Aaron Weitzman, Exelixis, South San Francisco, CA; and Paul Mainwaring, Hematology and Oncology Clinics of Australia, Brisbane, Queensland, Australia.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/34/25/3005.full.pdf
Web Search
http://dx.doi.org/10.1200/JCO.2015.65.5597DOI Listing
September 2016

Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma.

Expert Opin Drug Metab Toxicol 2016 Sep 29;12(9):1089-96. Epub 2016 Jul 29.

a Department of Medical Oncology , Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS , Meldola , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17425255.2016.1214713DOI Listing
September 2016

Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.

BioDrugs 2016 Aug;30(4):263-73

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40259-016-0176-3DOI Listing
August 2016

Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.

J Transl Med 2016 08 30;14(1):249. Epub 2016 Aug 30.

Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli 40, 47014, Meldola, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12967-016-1014-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006561PMC
August 2016